Study Identifies Gut Immune Mechanism in Multiple Sclerosis Neuroinflammation

A recent study has identified a key mechanism by which gut immune responses may initiate neuroinflammation in multiple sclerosis (MS). The research, published in Science Immunology, highlights the role of intestinal epithelial cells in activating pathogenic immune cells that subsequently migrate to the central nervous system, suggesting potential new therapeutic targets for the autoimmune disorder.

The research highlights the role of intestinal epithelial cells in activating pathogenic immune cells that subsequently migrate to the central nervous system, suggesting potential new therapeutic targets for the autoimmune disorder.

Understanding Multiple Sclerosis and the Gut Connection

Multiple sclerosis is a neurological disorder characterized by the immune system mistakenly attacking the brain and spinal cord, specifically targeting self-proteins such as myelin. Factors influencing MS onset and progression include genetic susceptibility, environmental triggers, and the gut microenvironment.

Patients with MS exhibit changes in their gut microbiota and potentially microbial metabolites, which are understood to contribute to autoreactive immune responses. However, the specific cellular mechanisms linking gut-derived signals to the immune system and influencing central nervous system (CNS) inflammation have remained unclear.

The specific cellular mechanisms linking gut-derived signals to the immune system and influencing central nervous system (CNS) inflammation have remained unclear.

New Research Uncovers Mechanistic Link

The study, led by Dr. Shohei Suzuki and Dr. Tomohisa Sujino at Keio University, Japan, aimed to clarify how gut microbes and intestinal immunity contribute to brain inflammation. This research builds on prior evidence suggesting the gut microbiota's influence on neurological diseases like Parkinson's, Alzheimer's, and MS. It was published online on March 27, 2026, in Science Immunology.

The team began by observing mild intestinal inflammation, specifically in the ileum, in experimental autoimmune encephalomyelitis (EAE), a mouse model for MS. They then investigated if similar inflammation occurred in human MS patients.

Key Discoveries

The study yielded several crucial findings that elucidate the gut-CNS axis in MS:

Single-cell RNA sequencing of intestinal biopsies revealed the accumulation of inflammatory Th17 cells in both EAE mice and the intestines of MS patients. This indicates an active and conserved gut-CNS axis in human disease.

Both EAE mice and MS patients showed an upregulation of antigen presentation pathways in intestinal epithelial cells. Ileal epithelial cells, in particular, exhibited increased expression of major histocompatibility complex class II (MHC II), a molecule that presents antigens to CD4+ T cells. While IECs do not typically present antigens to immune cells, co-culture assays demonstrated that IECs could directly present antigens in an MHC II-dependent manner, thereby priming CD4+ T cells in the gut. These assays also showed that IECs induced the polarization of activated CD4+ T cells into pro-inflammatory Th17 cells, identifying the gut as a critical site for immune activation of these pathogenic cells.

Ileal epithelial cells, in particular, exhibited increased expression of major histocompatibility complex class II (MHC II), a molecule that presents antigens to CD4+ T cells.

To determine if these gut-induced Th17 cells contribute to autoreactive cells in the CNS, transgenic mice expressing the Kaede protein were utilized. This protein undergoes photoconversion, enabling the tracking of pathogenic Th17 cells, which were induced in the intestinal lamina propria, as they migrated to the spinal cord and contributed to neuroinflammation.

Selective deletion of MHC II in IECs resulted in a reduction of pathogenic Th17 cell generation and a decrease in disease severity in the EAE model. This finding underscores the critical role of IECs in the disease pathway.

Implications for Treatment and Future Directions

The study concludes that MHC II expressed by intestinal epithelial cells plays a critical role in the expansion of pathogenic Th17 cells that subsequently migrate to the CNS during EAE. This research provides a mechanistic link between gut immune responses and autoimmune neuroinflammatory diseases.

Dr. Suzuki noted that while current MS therapies often target B cells, this study highlights the gut as a potentially significant therapeutic site. Modulating the intestinal microbiota or the antigen-presenting activity of intestinal epithelial cells could represent new approaches for treating autoimmune neurological diseases. An improved understanding of gut mucosal immune responses may assist in developing future therapeutics for conditions such as MS.

Modulating the intestinal microbiota or the antigen-presenting activity of intestinal epithelial cells could represent new approaches for treating autoimmune neurological diseases.